HIV-1 envelope sequence-based diversity measures for identifying recent infections

PLoS One. 2017 Dec 28;12(12):e0189999. doi: 10.1371/journal.pone.0189999. eCollection 2017.

Abstract

Identifying recent HIV-1 infections is crucial for monitoring HIV-1 incidence and optimizing public health prevention efforts. To identify recent HIV-1 infections, we evaluated and compared the performance of 4 sequence-based diversity measures including percent diversity, percent complexity, Shannon entropy and number of haplotypes targeting 13 genetic segments within the env gene of HIV-1. A total of 597 diagnostic samples obtained in 2013 and 2015 from recently and chronically HIV-1 infected individuals were selected. From the selected samples, 249 (134 from recent versus 115 from chronic infections) env coding regions, including V1-C5 of gp120 and the gp41 ectodomain of HIV-1, were successfully amplified and sequenced by next generation sequencing (NGS) using the Illumina MiSeq platform. The ability of the four sequence-based diversity measures to correctly identify recent HIV infections was evaluated using the frequency distribution curves, median and interquartile range and area under the curve (AUC) of the receiver operating characteristic (ROC). Comparing the median and interquartile range and evaluating the frequency distribution curves associated with the 4 sequence-based diversity measures, we observed that the percent diversity, number of haplotypes and Shannon entropy demonstrated significant potential to discriminate recent from chronic infections (p<0.0001). Using the AUC of ROC analysis, only the Shannon entropy measure within three HIV-1 env segments could accurately identify recent infections at a satisfactory level. The env segments were gp120 C2_1 (AUC = 0.806), gp120 C2_3 (AUC = 0.805) and gp120 V3 (AUC = 0.812). Our results clearly indicate that the Shannon entropy measure represents a useful tool for predicting HIV-1 infection recency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV Infections / diagnosis*
  • HIV Infections / genetics
  • HIV-1 / genetics*
  • High-Throughput Nucleotide Sequencing
  • Humans

Grants and funding

This study was supported by the Islamic Development Bank, the Fonds de la Recherche Québec-Santé (FRQ-S): Réseau SIDA/Maladies infectieuses, Québec, Canada, and the Genome Canada Grant. Alexis Kafando, PhD student, is beneficiary of: 1- Islamic Development Bank Merit Scholarship Programme For High Technology For 3 Year Ph. D (2013-2016), ID: 600014438, Jeddah, Saudi Arabia; 2- Bourse d’exemption des droits de scolarité supplémentaires pour étudiants étrangers of Université de Montréal, Montréal, Québec, Canada; 3- Bourse de fin d’études doctorales of Faculté des Etudes Supérieures et Postdoctorales (FESP) of Université de Montréal, Montréal, Québec, Canada; and 4-Bourse d’étude of Dre Tremblay’s laboratory at the Centre Hospitalier de l’Université de Montréal (FRQS RÉSEAU SIDA), Québec, Canada.